Answers are grounded in this paper and cite their sources.
Although prostaglandins (PGs) were reported to exert proinflammatory and anti-inflammatory effects in macrophages, their action mechanisms remain unclear. The effects of PGs including PGJ2 (J2), Δ12-PGJ2 (Δ12), 15-deoxy-Δ12,14 PGJ2 (15d), PGE2 (E2), and PGF2α (F2α) on lipopolysaccharide (LPS)–, lipoteichoic acid (LTA)–, and peptidoglycan (PGN)–induced inducible nitric oxide (NO) synthase (iNOS)/NO production by RAW264.7 macrophages were investigated. First, we found that induction of cyclooxygenase 2 (COX-2) protein occurred at a time earlier than that of heme oxygenase 1 (HO-1) protein, and the addition of the COX-2 inhibitor NS398 reduced HO-1 protein expression in LPS-, LTA-, and PGN-treated RAW264.7 macrophages. Incubation of RAW264.7 macrophages with the indicated PGs showed that J2, Δ12, and 15d significantly induced HO-1 protein expression; however, E2 and F2α did not. Heme oxygenase 1 protein induced by J2, Δ12, and 15d was inhibited by the transcriptional inhibitor, actinomycin (Act) D; the translational inhibitor, cycloheximide; and the antioxidant, N-acetyl cysteine (NAC). Increases in intracellular peroxide levels by J2, Δ12, and 15d were detected via a 2’,7’™-dichlorofluorescein diacetate (DCFH-DA) analysis, and they were prevented by the addition of NAC. In addition, J2, Δ12, and 15d produced significant inhibition of LPS-, LTA-, and PGN-induced iNOS protein and NO production by RAW264.7 cells, in accordance with increased HO-1 protein expression. Reductions of LPS-, LTA-, and PGN-induced phosphorylated c-Jun N-terminal kinase, c-Jun protein, and activator protein 1 luciferase activity by J2, Δ12, and 15d were identified, and the addition of the HO-1 inhibitor, tin protoporphyrin, reversed the inhibitory effects of Δ12 and 15d on LPS- and LTA-induced iNOS/NO, phosphorylated c-Jun N-terminal kinase, and c-Jun protein expressions by macrophages. Knockdown of HO-1 protein expression by HO-1 small interfering RNA blocked Δ12 and 15d inhibition of LPS- and LTA-induced events. Moreover, the compound, cyclopentenone (CP), which mimics the CP moiety of 15d, and its analog cyclohexenone were used, and cyclohexenone showed more potent induction of the HO-1 protein with effective inhibition of LPS-, LTA-, and PGN-induced iNOS/NO production than CP in macrophages. Reactive oxygen species–dependent HO-1 protein expression by PGs, which inhibited LPS-, LTA-, and PGN-induced iNOS/NO production, was identified in macrophages. ABBREVIATIONS Act D—actinomycin D AP-1—activator protein-1 BCIP—5-bromo-4-chloro-3-indolyl phosphate CH—cyclohexenone CHX—cycloheximide COX—cyclooxygenase CP—cyclopentenone DCFH-DA—2’,7’-dichlorofluorescein diacetate HO-1—heme oxygenase 1 iNOS—inducible nitric oxide synthase LPS—lipopolysaccharide LTA—lipoteicoic acid MTT—3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide NAC—N-acetyl cysteine NO—nitric oxide PGD2—prostaglandin D2 PGE2—prostaglandin E2 PGJ2—prostaglandin J2 PGF2α—prostaglandin F2α PGN—peptidoglycan ROS—reactive oxygen species siRNA—small interfering RNA SnPP—tin protoporphyrin
No takes yet. Share an insight, caveat, or question.
Chien et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: